Spruce Biosciences Hires Adrian Quartel as CMO — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Spruce Biosciences hired Adrian Quartel as chief medical officer, per the latest edition of STAT+'s "Up and down the ladder" personnel-moves column.
- Quartel previously held the same chief medical officer role at Zevra Therapeutics before joining Spruce.
- The column is a recurring STAT+ feature that spotlights one executive move each week in the life-sciences industry.
- The article invites readers to submit their own hires, promotions, and departures for inclusion in future installments.
- The full body of the column sits behind the STAT+ paywall; only the Quartel hire is visible in the open text.
Why it matters: CMO-level moves at clinical-stage biotechs like Spruce are worth tracking because they typically coincide with a drug pipeline shift — here, Quartel arrives from Zevra, a rare-disease company, suggesting Spruce may be leaning into a similar therapeutic lane as it scales its clinical leadership. For STAT+ subscribers, the column functions as a steady talent-flow dashboard across biopharma.
Ask SkimNews